Loading patent…
AssigneesMexbrain, Universite Claude Bernard Lyon 1, Institut Gustave Roussy, Centre National De La Recherche Scientifique
InventorsDaphné MOREL, Eric DEUTSCH, Olivier TILLEMENT, François LUX, Laurent DAVID, Fabien ROSSETTI, Arthur DURAND, Jordyn HOWARD, Elise ROSSON
Estimating the term…
The present disclosure relates to a functionalized polymer, for use in treating a disease correlated with heavy metal-induced toxicity or heavy metal-induced carcinogenicity in a subject in need thereof, wherein said functionalized polymer is soluble in aqueous solution, has a weight average molecular mass between 30 kDa and 5000 kDa, and wherein a part of the monomeric units are functionalized with a chelating moiety, wherein therapeutically efficient amount of said functionalized polymer is administered orally to the subject.
A method of using a functionalized polymer, for treating a disease correlated with heavy metal-induced toxicity or heavy metal-induced carcinogenicity in a subject in need thereof, wherein said functionalized polymer is soluble in an aqueous solution, wherein said functionalized polymer has an average molecular mass between kDa and 5000 kDa, wherein said functionalized polymer is comprised of monomeric units, wherein at least one of the monomeric units are functionalized with a chelating moiety, and wherein a therapeutically efficient amount of said functionalized polymer is administered orally to the subject.
Dependencies are inferred from the claim text.